Elevai Labs Inc. (ELAB): Growth-Adjusted Market Cap to Net Income

Corporate company logo of Elevai Corp (ELAB)

The PEG ratio trajectory demonstrates the valuation dynamics of Elevai Labs Inc. (ELAB), where the value of 0.00 expresses the metric level. The brand has earned recognition in aesthetic medicine through its safe exosomal developments. Elevai Labs Inc. (ELAB) implements tissue regeneration biotechnologies for rejuvenation, merging science and cosmetology. The high complexity of its products allows the firm to maintain premium status, avoiding price wars in the mass market segment.

PEG Multiple: Elevai Skincare (ELAB) for 02/21/2024 - 11/12/2026

Analytical breakdowns for Elevai Labs Inc. (ELAB)

- share price and consensus valuation forecast:
Price Performance Chart Elevai Labs Inc|ELAB - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Elevai Skincare|ELAB - Total Company Value
- company book value details:
Book Value per Share Elevai Labs|ELAB - Book Capitalization|Market Capitalization to Book Value elevaiskincare.com|ELAB - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Ratio Elevai Labs Inc.|ELAB - Long-Term Debt to Capital|Current Liabilities to Capital elevaiskincare.com|ELAB - Company Debts|Debt to Book Capitalization Ratio Elevai Skincare|ELAB - Company Long-Term Debts|Short-Term Debt Elevai Labs|Quick Liquidity elevaiskincare.com
- company profitability and valuation multiples indicators:
ELAB - Net Profit|Projected Future Earnings Elevai Labs Inc.|ELAB - P/E Multiple|Market Cap to Projected Earnings Elevai Corp|ELAB - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Elevai Skincare|ELAB - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Elevai Labs|ELAB - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth elevaiskincare.com|ELAB - Earnings growth in current year|Net earnings per share growth forecast for next year Elevai Labs Inc.
Fundamental company analysis:Elevai Labs Inc ELAB
Manufactured products of Elevai Skincare

As a portfolio manager, I view this indicator as a tool for benchmarking a business's market value against its expansion rate. By analyzing the P/E and growth balance, an investor assesses the efficiency of each unit of profit relative to scaling dynamics, which for Elevai Labs Inc. (ELAB) confirms investment attractiveness driven by high dermatologist loyalty to their innovative exosomal developments.

Competing companies

KRYS (Krystal Biotech Inc) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Apogee Pharma APGE|Growth-Adjusted Market Cap to Net Income Arcutis Corp (ARQT)|VCEL - Price/Earnings to Growth Ratio|ORKA - PEG Multiple|SMTI: PEG Multiple|DBVT - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Solesence Beauty|Growth-Adjusted P/E Ratio DERM (Journey Medical Corp.)|PEG Multiple FBRX|EMPG - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Sol-Gel Technologies Ltd. SLGL|AXIL Brands Inc - Price/Earnings to Growth Ratio|Medicus Pharma Limited - PEG Multiple|Price to Earnings Adjusted for Growth Rate Verrica Pharmaceuticals|HOTH (hoththerapeutics.com) - Price/Earnings to Growth Multiple|BFRI (Biofrontera) - Price/Earnings to Growth Ratio|VYNE (VYNE Therapeutics, Inc.) - PEG Multiple|PEG Multiple Sonoma Pharma|PEG Multiple QNRX|Growth-Adjusted Market Cap to Net Income Azitra Corporation|Dermata Therapeutics - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio RVNC